FCPM III SERVICES B.V. Long-Term Concentrated

CIK: 0002013410 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 8, 2024

Total Value ($000): $678,117 (100.0% shares, 0.0% debt)

Holdings (7)

DYN DYNE THERAPEUTICS INC 40.8%

Value ($000) $276,863 Shares 7,845,364 Est. Cost $12.58 Unrealized +131.1%

NAMS NEWAMSTERDAM PHARMA COMPANY 33.5%

Value ($000) $227,282 Shares 11,831,461 Est. Cost $9.16 Unrealized +119.0%

ENGN ENGENE HOLDINGS INC 12.1%

Value ($000) $81,833 Shares 8,677,951 Est. Cost $10.40 Unrealized +23.4%

REPL REPLIMUNE GROUP INC 6.5%

Value ($000) $43,798 Shares 4,866,449 Est. Cost $11.59 Unrealized -39.9%

BCYC BICYCLE THERAPEUTICS PLC 6.3%

Value ($000) $42,967 Shares 2,122,892 Est. Cost $20.24 Unrealized —

ENGNW ENGENE HOLDINGS INC 0.5%

Value ($000) $3,425 Shares 2,878,148 Est. Cost $0.63 Unrealized —

— ACHILLES THERAPEUTICS PLC 0.3%

Value ($000) $1,948 Shares 2,390,050 Est. Cost $0.89 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
DYN	DYNE THERAPEUTICS INC	7,845,364	$276,863	40.8%	$12.58	+131.1%	COM	26818M108
NAMS	NEWAMSTERDAM PHARMA COMPANY	11,831,461	$227,282	33.5%	$9.16	+119.0%	ORDINARY SHARES	N62509109
ENGN	ENGENE HOLDINGS INC	8,677,951	$81,833	12.1%	$10.40	+23.4%	COM	29286M105
REPL	REPLIMUNE GROUP INC	4,866,449	$43,798	6.5%	$11.59	-39.9%	COM	76029N106
BCYC	BICYCLE THERAPEUTICS PLC	2,122,892	$42,967	6.3%	$20.24	—	SPONSORED ADS	088786108
ENGNW	ENGENE HOLDINGS INC	2,878,148	$3,425	0.5%	$0.63	—	W EXP 10/31/2028	29286M113
—	ACHILLES THERAPEUTICS PLC	2,390,050	$1,948	0.3%	$0.89	—	SPONSORED ADS	00449L102